cytarabine has been researched along with Waldenstrom Macroglobulinemia in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuki, M; Hirano, K; Ito, K; Matsuda, S; Obayashi, M; Sekiguchi, N; Takaoka, K | 1 |
| Bashir, Q; Champlin, RE; Delgado, R; Hosing, C; Kebriaei, P; Lee, HC; Manasanch, EE; Mukherjee, A; Nieto, Y; Orlowski, RZ; Patel, KK; Patel, RD; Popat, U; Qazilbash, MH; Rondon, G; Saini, NY; Thomas, SK; Varma, A; Weber, DM | 1 |
| D'Sa, S; Dorman, J; Marzolini, MA; Thomson, KJ | 1 |
| Hashida, R; Hatano, M; Hori, M; Nishida, H; Obara, K | 1 |
| Dreyling, M | 1 |
| Holodny, A; Omuro, A; Palomba, ML; Pentsova, E; Rosenblum, M | 1 |
| Cabanillas, F; Dimopoulos, M; Gandhi, V; Gregoire, V; Kantarjian, H; Keating, MJ; Li, YY; McLaughlin, P; O'Brien, S; Robertson, LE | 1 |
| Amian, A; Cañavate, M; Diéguez, JC; Fernández-Jurado, A; Martino, ML; Moreno, MV; Polo, B; Prados, D; Quesada, JA; Rodríguez, JN | 1 |
| Bollinger, RO; Cejka, J; Chang, CH; Lusher, JM; Schuit, HR; Zuelzer, WW | 1 |
| LoSpalluto, J; Luby, JP; McCracken, GH; Weinberg, AG | 1 |
2 review(s) available for cytarabine and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
[Malignant lymphoma: individualized treatment according to biological and clinical risk factors].
Topics: Age Factors; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Products; Boronic Acids; Bortezomib; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Ki-1 Antigen; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Precision Medicine; Prognosis; Pyrazines; Risk Factors; Rituximab; Survival Rate; Waldenstrom Macroglobulinemia | 2011 |
The expanding role of fludarabine in hematologic malignancies.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Vidarabine; Waldenstrom Macroglobulinemia | 1994 |
8 other study(ies) available for cytarabine and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
An Autopsy Case of Bing-Neel Syndrome: Discrepancy between the Radiological and Pathological Findings.
Topics: Autopsy; Brain Diseases; Cytarabine; Dexamethasone; Fatal Outcome; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neurodegenerative Diseases; Radiography; Waldenstrom Macroglobulinemia | 2019 |
Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Podophyllotoxin; Survival Rate; Transplantation, Autologous; Waldenstrom Macroglobulinemia | 2019 |
BEAM-conditioned autologous SCT improves the quality of response in Waldenström's macroglobulinaemia and lymphoplasmacytic lymphoma: a single centre's 10-year experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Waldenstrom Macroglobulinemia | 2014 |
Optic nerve involvement of Waldenström's macroglobulinemia: with autopsy findings.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Blindness; Cytarabine; Disease Progression; Fatal Outcome; Humans; Lymphocytes; Magnetic Resonance Imaging; Male; Methotrexate; Optic Nerve; Prednisolone; Waldenstrom Macroglobulinemia | 2014 |
Chemotherapy-related magnetic resonance imaging abnormalities mimicking disease progression following intraventricular liposomal cytarabine and high dose methotrexate for neurolymphomatosis.
Topics: Aged; Antineoplastic Agents; Autopsy; Brain; Brain Injuries; Chlorambucil; Cytarabine; Disease Progression; Fatal Outcome; Humans; Injections, Spinal; Leukemia, Lymphocytic, Chronic, B-Cell; Magnetic Resonance Imaging; Male; Methotrexate; Nervous System Diseases; Positron-Emission Tomography; Recurrence; Waldenstrom Macroglobulinemia | 2012 |
[Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
Topics: Acute Disease; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Life Tables; Male; Myelodysplastic Syndromes; Prednisone; Remission Induction; Retrospective Studies; Survival Analysis; Survival Rate; Thioguanine; Treatment Outcome; Vincristine; Waldenstrom Macroglobulinemia | 1998 |
Macroglobulinemia in a child with acute leukemia.
Topics: Bence Jones Protein; Bone Marrow Cells; Child; Chromatography, Gel; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Electrophoresis; Fluorescent Antibody Technique; Humans; Immune Sera; Immunoelectrophoresis; Immunoglobulin Fab Fragments; Immunoglobulin Fc Fragments; Injections, Spinal; Leukemia; Male; Mercaptopurine; Methotrexate; Microscopy, Electron; Prednisone; Vincristine; Waldenstrom Macroglobulinemia | 1974 |
Monoclonal macroglobulinemia and cytomegalic inclusion disease.
Topics: Antibodies; Autopsy; Complement Fixation Tests; Complement System Proteins; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Immunodiffusion; Immunoglobulin Fragments; Immunoglobulin M; Immunologic Deficiency Syndromes; Infant; Liver; Lymphocyte Activation; Neutralization Tests; Pharynx; Pneumonia, Pneumocystis; Urine; Waldenstrom Macroglobulinemia | 1973 |